Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Thymmune Therapeutics
700 Main Street
Cambridge, MA 02139
https://www.thymmune.com/

Thymmune is a biotechnology company developing a machine learning-enabled thymic cell engineering platform to restore normal immune function in aging and disease. The company's cutting-edge approach in iPSC-thymic cell manufacturing can generate off-the-shelf cells at scale. The company is developing a pipeline of therapies to treat immunodeficiencies, transplant related, and autoimmune diseases.

Key Contact
Name
Bing Lim
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
03/01/23 $7,000,000 Seed NYBC Ventures
Pillar VC
undisclosed